Mathias Hukkelhoven

Director/Board Member at COMPUGEN LTD.

Net worth: 41 650 $ as of 30/09/2026

72 year

82 connections

Health Technology

Consumer Services

Finance

Profile

Mathias Hukkelhoven is currently an Independent Director at Compugen Ltd. since 2022 and a Partner at Panacea Venture Management Co., Ltd. Former positions include Chairman-Portfolio Stewardship at Novartis Pharmaceuticals Corp., Independent Non-Executive Director at Centessa Pharmaceuticals Plc from 2022 to 2026, Senior VP-Global Head Drug Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2001 to 2009, and SVP-Global Regulatory, Safety & Biometrics at Bristol-Myers Squibb (Israel) Ltd. from 2010 to 2021.
Education includes undergraduate and doctorate degrees from Radboud University Nijmegen.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
COMPUGEN LTD. 0.02%	29/07/2026	17,500 ( 0.02% )	41 650 $	30/09/2026

Mathias Hukkelhoven active positions

Companies	Position	Start
COMPUGEN LTD.	Director/Board Member	01/03/2022
Panacea Venture Management Co., Ltd. Panacea Venture Management Co., Ltd. Investment ManagersFinance Operates as a venture capital firm	Corporate Officer/Principal	-

All active positions of Mathias Hukkelhoven

Former positions of Mathias Hukkelhoven

Companies	Position	End
CENTESSA PHARMACEUTICALS PLC	Director/Board Member	24/06/2026
Bristol-Myers Squibb (Israel) Ltd.	General Counsel	01/07/2021
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions	General Counsel	01/01/2009
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions	Corporate Officer/Principal	-

See the detail of Mathias Hukkelhoven's experience

Education of Mathias Hukkelhoven

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mathias Hukkelhoven's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Compugen Ltd. Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics	Health Technology
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions	Health Technology
Radboud University Nijmegen Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bristol-Myers Squibb (Israel) Ltd.
Centessa Pharmaceuticals Plc Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders	Health Technology
Panacea Venture Management Co., Ltd. Panacea Venture Management Co., Ltd. Investment ManagersFinance Operates as a venture capital firm	Finance